Nootropic peptide (PRO8,GLY9,PRO10) Semax Acetate CAS 80714-61-0

Semax is a drug which is used mostly in Russia and Ukraine for a broad range of conditions but predominantly for its purported nootropicneuroprotective, and neurorestorative properties. Semax has not been evaluated, approved for use, or marketed in most other countries.


Semax acetate

ACTH (4-7), Pro-Gly-Pro-

CAS 80714-61-0

MF C37H51N9O10S

MW  813.92

Application Research purpose

Semax is an experimental drug that was originally developed back in Russia to prevent and treat circulatory disorders. It has also been identified as a “nootropic” or “cognitive enhancer.” Also known as the Heptapeptide SEMAX (MEHFPGP), it is the analog of ACTH.